Literature DB >> 34132117

Cross-species integration of single-cell RNA-seq resolved alveolar-epithelial transitional states in idiopathic pulmonary fibrosis.

Kevin Y Huang1, Enrico Petretto1.   

Abstract

Single-cell transcriptomics analyses of the fibrotic lung uncovered two cell states critical to lung injury recovery in the alveolar epithelium- a reparative transitional cell state in the mouse and a disease-specific cell state (KRT5-/KRT17+) in human idiopathic pulmonary fibrosis (IPF). The murine transitional cell state lies between the differentiation from type 2 (AT2) to type 1 pneumocyte (AT1), and the human KRT5-/KRT17+cell state may arise from the dysregulation of this differentiation process. We review major findings of single-cell transcriptomics analyses of the fibrotic lung and re-analyzed data from 7 single-cell RNA sequencing studies of human and murine models of IPF, focusing on the alveolar epithelium. Our comparative and cross-species single-cell transcriptomics analyses allowed us to further delineate the differentiation trajectories from AT2 to AT1 and AT2 to the KRT5-/KRT17+cell state. We observed AT1 cells in human IPF retain the transcriptional signature of the murine transitional cell state. Using pseudotime analysis, we recapitulated the differentiation trajectories from AT2 to AT1 and from AT2 to KRT5-/KRT17+ cell state in multiple human IPF studies. We further delineated transcriptional programs underlying cell state transitions and determined the molecular phenotypes at terminal differentiation. We hypothesize that in addition to the reactivation of developmental programs (SOX4, SOX9), senescence (TP63, SOX4) and the Notch pathway (HES1) are predicted to steer intermediate progenitors to the KRT5-/KRT17+cell state. Our analyses suggest that activation of SMAD3 later in the differentiation process may explain the fibrotic molecular phenotype typical of KRT5-/KRT17+cells.

Entities:  

Keywords:  Alveolar Epithelium; Cell-state Transition; Dysregulated Differentiation; Idiopathic Pulmonary Fibrosis; sc-RNAseq

Year:  2021        PMID: 34132117     DOI: 10.1152/ajplung.00594.2020

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  5 in total

Review 1.  Precision medicine in rheumatoid arthritis.

Authors:  Kartik Bhamidipati; Kevin Wei
Journal:  Best Pract Res Clin Rheumatol       Date:  2022-03-02       Impact factor: 4.098

Review 2.  Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis.

Authors:  Mengxia Shen; Ziqiang Luo; Yan Zhou
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

3.  Characterizing cellular heterogeneity in fibrotic hypersensitivity pneumonitis by single-cell transcriptional analysis.

Authors:  Junyi Wang; Lei Zhang; Li Luo; Ping He; Anying Xiong; Manling Jiang; Yao Liu; Shengbin Liu; Qin Ran; Dehong Wu; Ying Xiong; Xiang He; Guoping Li
Journal:  Cell Death Discov       Date:  2022-01-28

Review 4.  Exosomal Micro-RNAs as Intercellular Communicators in Idiopathic Pulmonary Fibrosis.

Authors:  María Cristina Negrete-García; Javier de Jesús Ramos-Abundis; Noé Alvarado-Vasquez; Eduardo Montes-Martínez; Martha Montaño; Carlos Ramos; Bettina Sommer
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

5.  RNA Sequencing of Epithelial Cell/Fibroblastic Foci Sandwich in Idiopathic Pulmonary Fibrosis: New Insights on the Signaling Pathway.

Authors:  Fiorella Calabrese; Francesca Lunardi; Veronica Tauro; Federica Pezzuto; Francesco Fortarezza; Luca Vedovelli; Eleonora Faccioli; Elisabetta Balestro; Marco Schiavon; Giovanni Esposito; Stefania Edith Vuljan; Chiara Giraudo; Dario Gregori; Federico Rea; Paolo Spagnolo
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.